Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diabetes

Free Subscription 24.08.2026 1 Am Heart J 1 Am J Cardiol 1 BMJ 1 Br J Ophthalmol 1 Circ Genom Precis Med 1 Diabet Med 3 Diabetes 19 Diabetes Care 16 Diabetes Obes Metab 3 Diabetologia 1 Hypertension 1 Invest Ophthalmol Vis Sci 1 J Am Coll Cardiol 1 J Clin Endocrinol Metab 1 J Diabetes Complications 1 J Pediatr 2 JAMA 7 Metabolism 1 Ophthalmology 1 PLoS Comput Biol 7 PLoS One 1 Proc Natl Acad Sci U S A 2 Retina

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. MARINACCI LX, Zheng Z, Liu M, Boyd A, et al
   Cardiometabolic health of low- and higher-income adults in the United States, 2009-2023.
   Am Heart J. 2026;301:107523.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

2. KHAN R, Brar S, Hosseini F, Malhi N, et al
   Examining the Association Between Diabetes and Cardiovascular Outcomes in South Asian Compared with White North American Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
   Am J Cardiol. 2026 Aug 15:S0002-9149(26)00526.
   PubMed         Abstract available
   
   

   
   BMJ

3. IACOBUCCI G
   Weekly type 2 diabetes insulin jab approved by NICE.
   BMJ. 2026;394:e100631.
   PubMed        
   
   

   
   Br J Ophthalmol

4. OLIVER C, Berkenstock MK, Sachdeva MM
   Association of fenofibrate use with progression of ocular disease in individuals with diabetes.
   Br J Ophthalmol. 2026 Aug 21:bjo-2026-329642. doi: 10.1136/bjo-2026-329642.
   PubMed         Abstract available
   
   

   
   Circ Genom Precis Med

5. REMALA S, Liang L, Shah AM, Buckley LF, et al
   Long-Term Efficacy and Safety of GLP-1R Agonist and SGLT2 Inhibitor Therapy in the General Population: A Mendelian Randomization Study.
   Circ Genom Precis Med. 2026;19:e005535.
   PubMed         Abstract available
   
   

   
   Diabet Med

6. KNOPH R, Norlev JTD, Kronborg T, Vestergaard P, et al
   The effect of telemonitoring on quality of life in people with insulin-treated type 2 diabetes: A secondary analysis of a randomised controlled trial.
   Diabet Med. 2026 Aug 18:e70448. doi: 10.1111/dme.70448.
   PubMed         Abstract available
   
   

   
   Diabetes

7. LU WB, Huang YS, Wu JC, Chen LW, et al
   Irisin Gene Delivery Elicits Sustained Amelioration of Diabetes in Akita Mice via Insulin-Independent Regulation of Hepatic Glucose Metabolism.
   Diabetes. 2026 Aug 21:db251158. doi: 10.2337/db25-1158.
   PubMed         Abstract available
   
   
8. PAGE B
   Diabetes Spotlight: John Ussher, PhD-Unlocking the Secret Cardiovascular Benefits of GLP-1-Based Medicines.
   Diabetes. 2026;75:1497-1498.
   PubMed        
   
   
9. FLAMMER ER, Higdon LE, Sanda S, Brusko TM, et al
   Baseline Serum Metabolites as Predictors of Teplizumab Response in Individuals With Type 1 Diabetes.
   Diabetes. 2026 Aug 18:db260158. doi: 10.2337/db26-0158.
   PubMed         Abstract available
   
   

   
   Diabetes Care

10. HOHSFIELD KR, Dong F, Waugh K, Steck AK, et al
    A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes.
    Diabetes Care. 2026;49:1700-1704.
    PubMed         Abstract available
    
    
11. RUNCHEY MC, Corapi S, Pavlou V, Cienfuegos S, et al
    Efficacy and Safety of Time-Restricted Eating in Adults With Type 1 Diabetes: A Randomized Controlled Trial.
    Diabetes Care. 2026 Aug 17:dc261093. doi: 10.2337/dc26-1093.
    PubMed         Abstract available
    
    
12. ROSS F, Ferranna M, Choe JH, Tortorice D, et al
    Beyond Health Outcomes: Broader Societal Impacts in Economic Evaluations of Type 1 Diabetes Technologies.
    Diabetes Care. 2026 Aug 17:dci260027. doi: 10.2337/dci26-0027.
    PubMed         Abstract available
    
    
13. LUK AOY, Lim LL, Chan JCN, Chow EWK, et al
    The Burden and Phenotype of Type 2 Diabetes in the Western Pacific Region.
    Diabetes Care. 2026 Aug 18:dci260055. doi: 10.2337/dci26-0055.
    PubMed         Abstract available
    
    
14. PATEL R, Uppal TS, Tomic D, Ali MK, et al
    Excess Burden of Inpatient Admissions and Emergency Department Visits Associated With Diabetes Across the Age Spectrum.
    Diabetes Care. 2026 Aug 18:dc260861. doi: 10.2337/dc26-0861.
    PubMed         Abstract available
    
    
15. MURRAY LEECH J, Sriram A, Colclough K, Hattersley AT, et al
    Clinical Utility of a Type 1 Diabetes Genetic Risk Score Measured as Part of MODY Genetic Testing.
    Diabetes Care. 2026 Aug 18:dc261081. doi: 10.2337/dc26-1081.
    PubMed         Abstract available
    
    
16. POP-BUSUI R, Repetto E, Baron J, Schumacher D, et al
    Response to Comment on Pop-Busui et al. Screening Natriuretic Peptide Levels Predicts Heart Failure and Death in Individuals With Type 1 and Type 2 Diabetes Without Known Heart Failure.
    Diabetes Care. 2026;49:e154-e155.
    PubMed        
    
    
17. HEDDERSON MM
    Gestational Diabetes Mellitus: Early Risk Factors, Prevention, Optimal Treatment, and Long-term Consequences for Mothers and Offspring: Reflections on 25 Years of Research: The 2025 Norbert Freinkel Award Lecture.
    Diabetes Care. 2026;49:1529-1538.
    PubMed         Abstract available
    
    
18. ZHANG Y, Wang J, Fan M, Chen M, et al
    Comment on Di Marco et al. Metabolic Factors Modulating the Connection Between Diabetes and Pulmonary Alterations.
    Diabetes Care. 2026;49:e156-e157.
    PubMed        
    
    
19. FUJISAWA K, Fujikawa T
    Comment on Pop-Busui et al. Screening Natriuretic Peptide Levels Predicts Heart Failure and Death in Individuals With Type 1 and Type 2 Diabetes Without Known Heart Failure.
    Diabetes Care. 2026;49:e153.
    PubMed        
    
    
20. LI Z, Di Marco M, Bodis KB, Wagner R, et al
    Response to Comment on Di Marco et al. Metabolic Factors Modulating the Connection Between Diabetes and Pulmonary Alterations.
    Diabetes Care. 2026;49:e158.
    PubMed        
    
    
21. YANG M, Li J, Li Y
    Comment on Luk et al. Precision Medicine to Redefine Insulin Secretion and Monogenic Diabetes (PRISM): A Randomized Controlled Trial in Chinese Patients With Young-Onset Diabetes.
    Diabetes Care. 2026;49:e167-e168.
    PubMed        
    
    
22. ZHANG Y, Liu J
    Comment on Ostrominski et al. Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial Emulations.
    Diabetes Care. 2026;49:e163-e164.
    PubMed        
    
    
23. PAGE B
    About the Editor: Adrian Vella, MD-Linking the TCF7L2 Gene and Type 2 Diabetes.
    Diabetes Care. 2026;49:1524.
    PubMed        
    
    
24. SEIGLIE JA, Seuring T, Teufel F, Marcus ME, et al
    Waist Circumference, Relative Fat Mass Index, and BMI as Classifiers of Diabetes Status: A Comparative, Cross-sectional Analysis in 82 Low- and Middle-Income Countries.
    Diabetes Care. 2026;49:1654-1662.
    PubMed         Abstract available
    
    
25. SWEETING A
    Defining Clinical Heterogeneity in Gestational Diabetes Mellitus: The Importance of Timing and Severity of Maternal Hyperglycemia.
    Diabetes Care. 2026;49:1549-1550.
    PubMed        
    
    
26. LALANI B, Mathioudakis N
    The U.S. National Diabetes Prevention Program Demonstrates Effectiveness With Insufficient Reach.
    Diabetes Care. 2026;49:1551-1553.
    PubMed        
    
    
27. QIAN L, Surmont F, Ji L
    Recent Advances in Diabetes Therapies in Asia.
    Diabetes Care. 2026 Aug 21:dci260057. doi: 10.2337/dci26-0057.
    PubMed         Abstract available
    
    
28. SO M, Waibel M, Couper JJ, Cameron FJ, et al
    beta-Cell Function and Diabetes Outcomes 1 Year After Stopping Oral Baricitinib Immunotherapy for Type 1 Diabetes.
    Diabetes Care. 2026 Aug 21:dc261072. doi: 10.2337/dc26-1072.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

29. GARCIA-GONZALEZ A, Matamoros-Dominguez A, Espinosa-Cabello JM, Perez-Munoz G, et al
    Oleanolic Acid-Enriched Olive Oil Attenuates Kidney Function Decline in Patients With Type 2 Diabetes: Results From the OLTRAD Randomised Controlled Trial.
    Diabetes Obes Metab. 2026 Aug 17. doi: 10.1111/dom.71206.
    PubMed         Abstract available
    
    
30. IGNACY P, Aldosari H, Irlik K, Gut-Misiaga M, et al
    Artificial Intelligence Analysis of Standard 12-Lead Electrocardiograms for Screening of Symptomatic Diabetic Peripheral Neuropathy.
    Diabetes Obes Metab. 2026 Aug 19. doi: 10.1111/dom.71240.
    PubMed         Abstract available
    
    
31. 
    Correction to "An International Consensus on Screening and Monitoring Early-Stage Type 1 Diabetes: A Roadmap to European Implementation".
    Diabetes Obes Metab. 2026 Aug 19. doi: 10.1111/dom.71229.
    PubMed        
    
    
32. NICESE MN, Koudijs A, Lalai R, Avramut C, et al
    Oral Butyrate Reduces Progression of Kidney Damage in an L-NAME-Induced Diabetic Kidney Disease Mouse Model.
    Diabetes Obes Metab. 2026 Aug 18. doi: 10.1111/dom.71245.
    PubMed         Abstract available
    
    
33. ISHIBASHI R, Koshizaka M, Hirayama K, Sakai T, et al
    Baseline HDL Cholesterol and the Anti-VEGF Injection-Sparing Effect of an SGLT2 Inhibitor in Diabetic Macular Oedema: A Post Hoc Analysis of the COMET Trial.
    Diabetes Obes Metab. 2026 Aug 18. doi: 10.1111/dom.71223.
    PubMed        
    
    
34. CARRETERO-ANIBARRO E, Quesada JA, Ruiz-Quintero MA, Mauricio D, et al
    Association of Lipid Ratios With Cardiovascular Outcomes in Type 2 Diabetes: A Population Cohort Study.
    Diabetes Obes Metab. 2026 Aug 17. doi: 10.1111/dom.71236.
    PubMed         Abstract available
    
    
35. ZHAO R, Zhu Y, Liu Y, Yuan Z, et al
    Integrative Proteomics-Metabolomics Profiling of Umbilical Cord Plasma With Machine Learning Reveals Candidate Biomarkers for Gestational Diabetes Mellitus.
    Diabetes Obes Metab. 2026 Aug 17. doi: 10.1111/dom.71241.
    PubMed         Abstract available
    
    
36. CHOI M, Lee S, Bang E, Seo I, et al
    Vegetable-First Meal Sequence Suppresses Postprandial Glycaemic Excursions and Variability in Young Women With High-Risk Phenotype for Early-Onset Type 2 Diabetes: A 4-Arm Randomized Crossover Trial With Continuous Glucose Monitoring.
    Diabetes Obes Metab. 2026 Aug 17. doi: 10.1111/dom.71227.
    PubMed         Abstract available
    
    
37. LI Y, Liu X, Shang L, Wang Y, et al
    When Metabolically Healthy Is Not Low Risk: BMI Thresholds for Incident Diabetes in East Asian Adults.
    Diabetes Obes Metab. 2026 Aug 17. doi: 10.1111/dom.71235.
    PubMed         Abstract available
    
    
38. SZYMANSKA-GARBACZ E, Czupryniak L
    Interpreting Low Glucose Values Below 3.9 mmol/L (70 mg/dL) in People Without Diabetes in the Era of Continuous Glucose Monitoring.
    Diabetes Obes Metab. 2026 Aug 17. doi: 10.1111/dom.71243.
    PubMed        
    
    
39. RUOTOLO G, Harris C, Lin Y, Wilson JM, et al
    Retatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Aug 17. doi: 10.1111/dom.71200.
    PubMed         Abstract available
    
    
40. LI Y, Hu Z, Chen L, Jia H, et al
    Phenotypic Heterogeneity of Diabetic Kidney Disease and Its Association With Cardiovascular and Renal Outcomes: Evidence From a Chinese Multicentre Cohort.
    Diabetes Obes Metab. 2026 Aug 17. doi: 10.1111/dom.71239.
    PubMed         Abstract available
    
    
41. MILDER TY, Shepherd L, Raket HK, Greenfield JR, et al
    Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Aug 17. doi: 10.1111/dom.71219.
    PubMed         Abstract available
    
    
42. HAO Z, Pi L, Zhang J, Deng Y, et al
    EASO's New Obesity Framework and Incident Type 2 Diabetes: A Prospective Cohort Study.
    Diabetes Obes Metab. 2026 Aug 17. doi: 10.1111/dom.71232.
    PubMed         Abstract available
    
    
43. MIYAKE T, Yoshida O, Furukawa S, Hirooka M, et al
    Efficacy of Luseogliflozin Added to Semaglutide in Patients With Metabolic Dysfunction-Associated Steatohepatitis and Type 2 Diabetes Mellitus: A Randomised, Open-Label Trial.
    Diabetes Obes Metab. 2026 Aug 17. doi: 10.1111/dom.71233.
    PubMed         Abstract available
    
    
44. RAMA CHANDRAN S, Ang WM, Lim GH, Sng GGR, et al
    An Observational Study on the Impact of Menstrual Cycle Phases on Carbohydrate Intake, Insulin Delivery and Glycaemia in Women With Type 1 Diabetes Using MiniMed 780G Automated Insulin Delivery System.
    Diabetes Obes Metab. 2026 Aug 17. doi: 10.1111/dom.71234.
    PubMed         Abstract available
    
    

    
    Diabetologia

45. YKI-JARVINEN H, Roden M
    The liver in diabetes: current state and future perspectives.
    Diabetologia. 2026 Aug 15. doi: 10.1007/s00125-026-06827.
    PubMed         Abstract available
    
    
46. ADLY AAM, Ismail EAR, Abdel Kader MSEM, Sadeq MR, et al
    Dulaglutide vs insulin in adolescents with thalassaemia-induced diabetes: effect on metabolism and atherogenesis (DIADEMA).
    Diabetologia. 2026 Aug 19. doi: 10.1007/s00125-026-06835.
    PubMed         Abstract available
    
    
47. SCHARFMANN R, Zaldumbide A
    Pancreatic islets: new discoveries for innovative treatments of diabetes?
    Diabetologia. 2026 Aug 21. doi: 10.1007/s00125-026-06839.
    PubMed         Abstract available
    
    

    
    Hypertension

48. AGARWAL R, Correa-Rotter R, Navaneethan SD, Heerspink HJL, et al
    Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.
    Hypertension. 2026;83:e27036.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

49. HUANG Z, Jian L, Xiang J, Du Y, et al
    Triglyceride-Glucose-Related Indexes as Risk Factors for Vision-Threatening Ocular Diseases: A Prospective UK Biobank Study.
    Invest Ophthalmol Vis Sci. 2026;67:48.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

50. TAYLOR-SWEET D, Petrie MC, McKinley G, McGlynn L, et al
    Targeted Assessment in High-Risk Patients With Diabetes to Identify Undiagnosed Heart Failure (TARTAN-HF).
    J Am Coll Cardiol. 2026 Aug 11:S0735-1097(26)07132.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

51. SHIMABUKURO M, Watanabe-Shimoji K, Tanabe H, Kawakami E, et al
    Data-Driven Diabetes Clustering in East Asians: Pathological Heterogeneity and Personalized Medicine.
    J Clin Endocrinol Metab. 2026 Aug 17:dgag338. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

52. TAKIYAMA T, Kitsunai H, Maruyama F, Kitao N, et al
    Clinical efficacy of switching to tirzepatide in patients with type 2 diabetes and a high risk of metabolic dysfunction-associated steatotic liver disease undergoing GLP-1 receptor agonist therapy: Insights from the Hokkaido-TZP study.
    J Diabetes Complications. 2026 Aug 14:109391.
    PubMed         Abstract available
    
    

    
    J Pediatr

53. ADDALA A, Ritter V, Shaw B, Bishop FK, et al
    Mitigating Glycemic Disparities: Understanding Contributions of Sociodemographic Variables in the Teamwork, Targets, Technology, and Tight Glycemia (4T) Study.
    J Pediatr. 2026;296:115156.
    PubMed         Abstract available
    
    

    
    JAMA

54. SALIVE ME, Tjaden AH, Ames JR, Crandall JP, et al
    Lifestyle and Metformin Interventions and Risk of Multimorbidity in Adults With Prediabetes.
    JAMA. 2026;336:577-586.
    PubMed         Abstract available
    
    
55. ANDERER S
    GLP-1 Drugs Linked to Lower Fracture Risk in People With Type 2 Diabetes.
    JAMA. 2026 Aug 21. doi: 10.1001/jama.2026.12059.
    PubMed        
    
    

    
    Metabolism

56. YANNAKOULIA MU, Kontogianni MuD, Antonopoulou S, Fragopoulou E, et al
    Mediterranean diet: definitions, health effects and metabolic pathways - evidence and future directions.
    Metabolism. 2026;183:156690.
    PubMed         Abstract available
    
    
57. JAYABASKARAN J, Nagarajan S, Himan HR, Kok J, et al
    Global and regional projections of atherosclerotic cardiovascular-kidney-liver-metabolic disease burden to 2050: a forecasting analysis for the global burden of disease study 2023.
    Metabolism. 2026;183:156716.
    PubMed         Abstract available
    
    
58. WANG L, Jiang F, Yuan S, Sun J, et al
    Complementary body weight and cardiometabolic benefits of higher GLP-1 and lower GIP: genetic evidence from large-scale phenomic analyses.
    Metabolism. 2026;183:156711.
    PubMed         Abstract available
    
    
59. JHUANG HY, Lee JY, Wang LT
    Mesenchymal stem cell therapy for diabetes: clinical evidence, emerging strategies, and future perspectives.
    Metabolism. 2026;184:156748.
    PubMed         Abstract available
    
    
60. ZHANG F, Wang Z
    Hypercortisolism screening in obesity and diabetes.
    Metabolism. 2026 Aug 19:156746. doi: 10.1016/j.metabol.2026.156746.
    PubMed        
    
    
61. FERRARI D, Corona G, Isidori A
    Response to Letter to the Editor regarding "Rethinking hypercortisolism screening in obesity and diabetes: A systematic review and meta-analysis" by Ferrari et Al. Metabolism. 2026 Sep;182:156675.
    Metabolism. 2026 Aug 20:156735. doi: 10.1016/j.metabol.2026.156735.
    PubMed        
    
    
62. LI Y, Ma C, Tong Z, Zhong M, et al
    Beyond fibrosis: Metabolic memory and cellular fate in diabetic skeletal muscle remodeling: Response letter.
    Metabolism. 2026 Aug 21:156749. doi: 10.1016/j.metabol.2026.156749.
    PubMed        
    
    

    
    Ophthalmology

63. VANDERBEEK BL
    Understanding the Neurodegenerative Changes in Diabetic Retinal Disease.
    Ophthalmology. 2026 Aug 20:S0161-6420(26)00528.
    PubMed        
    
    

    
    PLoS Comput Biol

64. LAN W, Wang D, Chen W, Yan X, et al
    ERFMTDA: Predicting tsRNA-disease associations using an enhanced rotative factorization machine.
    PLoS Comput Biol. 2026;22:e1014594.
    PubMed         Abstract available
    
    

    
    PLoS One

65. HU X, Li Y, Luo B, Wang Y, et al
    A multimodal analysis suggests partial IRF8/TLR7-associated myeloid transcriptional convergence between diabetic kidney disease and Parkinson's disease.
    PLoS One. 2026;21:e0356691.
    PubMed         Abstract available
    
    
66. BARBOZA-PANAIFO S, Erazo-Cardenas I, Chaponan-Agip NV, Tenorio-Quispe A, et al
    High prevalence of resistance to first-line drugs and multidrug resistance in patients with tuberculosis and type 2 diabetes mellitus at a referral hospital in Peru.
    PLoS One. 2026;21:e0337152.
    PubMed         Abstract available
    
    
67. KAZMI M, Imran B, Qazi SA, Siddiqui MAR, et al
    A generalizability analysis framework for bias resilience in convolution neural network and transformer models for diabetic retinopathy screening.
    PLoS One. 2026;21:e0351225.
    PubMed         Abstract available
    
    
68. NONG Y, Huang H, Xu X, Tan X, et al
    Association of air pollution with diabetic microvascular complications: A prospective cohort study.
    PLoS One. 2026;21:e0354711.
    PubMed         Abstract available
    
    
69. PUNTERVOLD OE, Heinsvig PJ, Skytte MG, Olsen KB, et al
    Targeted metabolomics of postmortem human cardiac tissue using the Biocrates MxP Quant 500 kit.
    PLoS One. 2026;21:e0356269.
    PubMed         Abstract available
    
    
70. VAN WILDER L, Janssens N, Van Hoorenbeeck K, Vanden Wyngaert K, et al
    The COCCOS study: A protocol for a multicentric quasi-experimental study of a healthcare transition program for young people with chronic conditions.
    PLoS One. 2026;21:e0353932.
    PubMed         Abstract available
    
    
71. GE J, Lu P, Peng S, Huang H, et al
    Nonlinear relationship between sleep quality and prevalence of type 2 diabetes: A cross-sectional study of community patients with chronic diseases.
    PLoS One. 2026;21:e0356250.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

72. ZHANG YC, Ding ZQ, Xu SY, Chen JY, et al
    ALKBH3 inhibition normalizes neovessels by reprogramming endothelial fate in diabetic microvasculopathy.
    Proc Natl Acad Sci U S A. 2026;123:e2602779123.
    PubMed         Abstract available
    
    

    
    Retina

73. WANG Y, Kong X, Wang J, Zhou W, et al
    The impact of renal function on pars plana vitrectomy for proliferative diabetic retinopathy and analysis of prognosis.
    Retina. 2026 Aug 21. doi: 10.1097/IAE.0000000000004972.
    PubMed         Abstract available
    
    
74. WANG S, Wang Y, Li D, Wen L, et al
    Temporal Sector Thickening of the Retinal Nerve Fiber Layer as a Structural Marker of Diabetic Retinopathy Severity in Chinese Adults with Type 2 Diabetes Mellitus.
    Retina. 2026 Aug 17. doi: 10.1097/IAE.0000000000004969.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum